1. |
Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the global burden of disease study 2013. Lancet, 2016, 387(10015): 251-272.
|
2. |
Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the global burden of disease study 2010. Lancet, 2014, 383(9913): 245-254.
|
3. |
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016. Lancet, 2017, 390(10100): 1151-1210.
|
4. |
Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol, 2007, 6(5): 456-464.
|
5. |
Guan T, Ma J, Li M, et al. Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013. Neurology, 2017, 89(1): 53-61.
|
6. |
Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480687 adults. Circulation, 2017, 135(8): 759-771.
|
7. |
Chen Z, Peto R, Zhou M, et al. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet, 2015, 386(10002): 1447-1456.
|
8. |
Millwood IY, Li L, Smith M, et al. Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates. Int J Epidemiol, 2013, 42(3): 816-827.
|
9. |
Huo Y, Li J1, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA, 2015, 313(13): 1325-1335.
|
10. |
He J, Zhang Y, Xu T, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA, 2014, 311(5): 479-489.
|
11. |
Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med, 2013, 369(1): 11-19.
|
12. |
Zhang S, Wu B, Liu M, et al. Acupuncture efficacy on ischemic stroke recovery: multicenter randomized controlled trial in China. Stroke, 2015, 46(5): 1301-1306.
|
13. |
Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol, 2019, 18(4): 394-405.
|
14. |
国家卫生计生委统计信息中心. 2013第五次国家卫生服务调查分析报告. 北京: 中国协和医科大学出版社, 2015.
|
15. |
GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations: a systematic analysis from the global burden of disease study 2016. Lancet, 2018, 391(10136): 2236-2271.
|
16. |
Li Y, Yang L, Wang L, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol, 2017, 227: 516-523.
|
17. |
Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012-2015. Circulation, 2018, 137(22): 2344-2356.
|
18. |
Lu Y, Wang P, Zhou T, et al. Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States. J Am Heart Assoc, 2018, 26, 7(3): e007462.
|
19. |
Falaschetti E, Mindell J, Knott C, et al. Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet, 2014, 383(9932): 1912-1919.
|
20. |
Pan L, Yang Z, Wu Y, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis, 2016, 248: 2-9.
|
21. |
Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA, 2017, 317(24): 2515-2523.
|
22. |
Wang M, Luo X, Xu S, et al. Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013. Lancet Respir Med, 2019, 7(1): 35-45.
|
23. |
Brauer M, Freedman G, Frostad J, et al. Ambient air pollution exposure estimation for the global burden of disease 2013. Environ Sci Technol, 2016, 50(1): 79-88.
|
24. |
Yu K, Qiu G, Chan KH, et al. Association of solid fuel use with risk of cardiovascular and all-cause mortality in rural china. JAMA, 2018, 319(13): 1351-1361.
|
25. |
Luo L, Jiang J, Zhang G, et al. Stroke mortality attributable to ambient particulate matter pollution from 1990 to 2015 in China: an age-period-cohort and spatial autocorrelation analysis. Int J Environ Res Public Health, 2017, 14(7): 772.
|
26. |
Li Y, He Y, Lai J, et al. Dietary patterns are associated with stroke in Chinese adults. J Nutr, 2011, 141(10): 1834-1839.
|
27. |
Wang X, Wu Y, Zhang X, et al. Dietary changes over 25 years in Tianjin residents: findings from the 1986-1988, 2000-2004, and 2008-2011 nutrition surveys. Nutrients, 2016, 8(2): 62.
|
28. |
Anderson CA, Appel LJ, Okuda N, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc, 2010, 110(5): 736-745.
|
29. |
Li J, Liu J, Ma Y, et al. Imbalanced regional development of acute ischemic stroke care in emergency departments in China. Emerg Med Int, 2019, 2019: 3747910.
|
30. |
Lin S, Wu B, Hao ZL, et al. Characteristics, treatment and outcome of ischemic stroke with atrial fibrillation in a Chinese hospital-based stroke study. Cerebrovasc Dis, 2011, 31(5): 419-426.
|
31. |
Tao WD, Liu M, Fisher M, et al. Posterior versus anterior circulation infarction: how different are the neurological deficits?. Stroke, 2012, 43(8): 2060-2065.
|
32. |
Hao Z, Chang X, Zhou H, et al. A cohort study of decompressive craniectomy for malignant middle cerebral artery infarction: a real-world experience in clinical practice. Medicine (Baltimore), 2015, 94(25): e1039.
|
33. |
Wu S, Yuan R, Xiong Y, et al. Clinical features, management and outcomes of severe ischaemic stroke in tertiary hospitals in China: protocol for a prospective multicentre registry-based observational study. BMJ Open, 2018, 8(10): e024900.
|